Transforming Addiction Treatment in Prisons: A Chat with Dr. Sharif Nankoe
Episode Overview
Treating addiction in jails is a human rights issue. Stigma around addiction needs to be addressed. Injectable buprenorphine can ease treatment processes. Effective treatment reduces recidivism rates. Medical oversight is crucial for successful MOUD programs.
It's really about putting substance use disorder on par with other chronic conditions - it's a human rights issue.
Imagine being in a place where your options for getting help with addiction are limited. In this episode of Airing Addiction, Dr. Sharif Nankoe, the Chief Medical Director for Department of Corrections Programs at Spectrum Health Systems, dives into the critical topic of treating opioid use disorder in jails and prisons. With over 20 correctional MOUD (Medication for Opioid Use Disorder) programs under his belt, Dr.
Nankoe shares his expertise and passion for providing essential medical care to some of the most vulnerable populations. Hosted by Lisa Blanchard and Jesse Chaison, this episode is packed with eye-opening discussions about the challenges and opportunities in correctional settings. Dr. Nankoe explains why treating addiction in these environments is not just a medical necessity but a human rights issue.
He also sheds light on the stigma surrounding addiction and the importance of viewing it as a chronic medical condition rather than a moral failing. From the high risk of overdose post-release to the benefits of injectable buprenorphine, you'll gain valuable insights into the complexities of addiction treatment in correctional facilities. Dr. Nankoe's personal journey and dedication to social justice make this episode both informative and inspiring.
If you're interested in understanding how effective treatment can reduce recidivism and improve lives, this episode is a must-listen.